Andersson K E, Bergdahl B, Dencker H, Wettrell G
Eur J Clin Pharmacol. 1977 Apr 20;11(4):277-81. doi: 10.1007/BF00607677.
The absorption of proscillaridin A was studied in four patients undergoing catheterization of the portal vein for diagnostic purposes. Proscillaridin 1.5 mg was given as a single oral dose and plasma glycoside activity was analyzed by the 86Rb-uptake inhibition technique. Proscillaridin appeared rapidly in the portal blood, peak activity being found after 15 min in three and after 30 min in one patient. In peripheral blood the peak activity occurred after approximately 35 min. Despite rapid passage across the gut wall, porto-peripheral differences in glycoside activity were small; they were zero after 4h. The mean amount absorbed as active porscillaridin during the first 4h after the dose was calculated to be only 7.1% of the given amount. Late porto-peripheral differences, probably due to enterohepatic recycling, appeared after 6h in three patients; The results suggest that proscillaridin undergoes first pass inactivation in the gut wall. Enterohepatic recirculation may contribute to the amounts of active glycoside that reach the systemic circulation.
对4例因诊断目的而行门静脉插管的患者进行了海葱苷A吸收情况的研究。口服单剂量1.5mg海葱苷A,采用86Rb摄取抑制技术分析血浆糖苷活性。海葱苷在门静脉血中迅速出现,3例患者在15分钟后出现活性峰值,1例患者在30分钟后出现活性峰值。在外周血中,活性峰值约在35分钟后出现。尽管海葱苷能迅速穿过肠壁,但糖苷活性的门脉-外周差异较小;4小时后差异为零。给药后前4小时内吸收的活性海葱苷平均量经计算仅为给药量的7.1%。3例患者在6小时后出现晚期门脉-外周差异,这可能是由于肠肝循环所致;结果表明,海葱苷在肠壁中经历首过灭活。肠肝循环可能有助于活性糖苷进入体循环的量。